Cargando…

Explaining the Association Between Fetal Growth and Childhood ADHD Symptoms: Cross-cohort Replication

The association between restricted fetal growth and symptoms of attention deficit/hyperactivity disorder (ADHD) in childhood is well-replicated and robust. However, fetal growth is determined by many prenatal factors and associations with mental health may be confounded by familial and social contex...

Descripción completa

Detalles Bibliográficos
Autores principales: Dooley, Niamh, Healy, Colm, Brannigan, Ross, Cotter, David, Clarke, Mary, Cannon, Mary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867674/
https://www.ncbi.nlm.nih.gov/pubmed/36114937
http://dx.doi.org/10.1007/s10802-022-00971-9
_version_ 1784876396421578752
author Dooley, Niamh
Healy, Colm
Brannigan, Ross
Cotter, David
Clarke, Mary
Cannon, Mary
author_facet Dooley, Niamh
Healy, Colm
Brannigan, Ross
Cotter, David
Clarke, Mary
Cannon, Mary
author_sort Dooley, Niamh
collection PubMed
description The association between restricted fetal growth and symptoms of attention deficit/hyperactivity disorder (ADHD) in childhood is well-replicated and robust. However, fetal growth is determined by many prenatal factors and associations with mental health may be confounded by familial and social context. In this study, we sought to quantify the relative contributions of prenatal factors and familial confounds to the association between fetal growth and ADHD symptoms. Two independent cohorts were analyzed, the Adolescent Brain Cognitive Development study (ABCD; United States) and the Growing Up in Ireland (GUI) study. ADHD symptoms were measured by the Child Behavior Checklist (ABCD) and the Strengths & Difficulties questionnaire (GUI) at age 9–10. Using sequential regression models, we assessed the change-in-association between fetal growth and ADHD symptoms after controlling for sex, familial factors (socioeconomic/demographic factors & family psychiatric history) and prenatal factors (pregnancy complications & maternal substance-use during pregnancy). Converging findings from cohorts suggested that over a quarter of the association between fetal growth and ADHD symptoms is attributable to familial confounds. The degree to which the association was explained by prenatal factors differed by cohort—pregnancy complications explained a larger proportion of the effect in ABCD (7.9%) than GUI (2.7%), and maternal substance-use explained a larger proportion of the effect in GUI (22.7%) compared to ABCD (4.8%). Different explanations of the fetal growth-ADHD association across cohorts suggests cohort-specific, and potentially nationally-specific, risk factors for fetal growth and related neurodevelopmental outcomes. The evidence suggests early prevention of ADHD in Ireland should focus on minimizing maternal smoking during pregnancy. In the US, prevention and treatment of pregnancy complications are highlighted as viable targets for intervention. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10802-022-00971-9.
format Online
Article
Text
id pubmed-9867674
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-98676742023-01-23 Explaining the Association Between Fetal Growth and Childhood ADHD Symptoms: Cross-cohort Replication Dooley, Niamh Healy, Colm Brannigan, Ross Cotter, David Clarke, Mary Cannon, Mary Res Child Adolesc Psychopathol Article The association between restricted fetal growth and symptoms of attention deficit/hyperactivity disorder (ADHD) in childhood is well-replicated and robust. However, fetal growth is determined by many prenatal factors and associations with mental health may be confounded by familial and social context. In this study, we sought to quantify the relative contributions of prenatal factors and familial confounds to the association between fetal growth and ADHD symptoms. Two independent cohorts were analyzed, the Adolescent Brain Cognitive Development study (ABCD; United States) and the Growing Up in Ireland (GUI) study. ADHD symptoms were measured by the Child Behavior Checklist (ABCD) and the Strengths & Difficulties questionnaire (GUI) at age 9–10. Using sequential regression models, we assessed the change-in-association between fetal growth and ADHD symptoms after controlling for sex, familial factors (socioeconomic/demographic factors & family psychiatric history) and prenatal factors (pregnancy complications & maternal substance-use during pregnancy). Converging findings from cohorts suggested that over a quarter of the association between fetal growth and ADHD symptoms is attributable to familial confounds. The degree to which the association was explained by prenatal factors differed by cohort—pregnancy complications explained a larger proportion of the effect in ABCD (7.9%) than GUI (2.7%), and maternal substance-use explained a larger proportion of the effect in GUI (22.7%) compared to ABCD (4.8%). Different explanations of the fetal growth-ADHD association across cohorts suggests cohort-specific, and potentially nationally-specific, risk factors for fetal growth and related neurodevelopmental outcomes. The evidence suggests early prevention of ADHD in Ireland should focus on minimizing maternal smoking during pregnancy. In the US, prevention and treatment of pregnancy complications are highlighted as viable targets for intervention. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10802-022-00971-9. Springer US 2022-09-17 2023 /pmc/articles/PMC9867674/ /pubmed/36114937 http://dx.doi.org/10.1007/s10802-022-00971-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Dooley, Niamh
Healy, Colm
Brannigan, Ross
Cotter, David
Clarke, Mary
Cannon, Mary
Explaining the Association Between Fetal Growth and Childhood ADHD Symptoms: Cross-cohort Replication
title Explaining the Association Between Fetal Growth and Childhood ADHD Symptoms: Cross-cohort Replication
title_full Explaining the Association Between Fetal Growth and Childhood ADHD Symptoms: Cross-cohort Replication
title_fullStr Explaining the Association Between Fetal Growth and Childhood ADHD Symptoms: Cross-cohort Replication
title_full_unstemmed Explaining the Association Between Fetal Growth and Childhood ADHD Symptoms: Cross-cohort Replication
title_short Explaining the Association Between Fetal Growth and Childhood ADHD Symptoms: Cross-cohort Replication
title_sort explaining the association between fetal growth and childhood adhd symptoms: cross-cohort replication
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867674/
https://www.ncbi.nlm.nih.gov/pubmed/36114937
http://dx.doi.org/10.1007/s10802-022-00971-9
work_keys_str_mv AT dooleyniamh explainingtheassociationbetweenfetalgrowthandchildhoodadhdsymptomscrosscohortreplication
AT healycolm explainingtheassociationbetweenfetalgrowthandchildhoodadhdsymptomscrosscohortreplication
AT branniganross explainingtheassociationbetweenfetalgrowthandchildhoodadhdsymptomscrosscohortreplication
AT cotterdavid explainingtheassociationbetweenfetalgrowthandchildhoodadhdsymptomscrosscohortreplication
AT clarkemary explainingtheassociationbetweenfetalgrowthandchildhoodadhdsymptomscrosscohortreplication
AT cannonmary explainingtheassociationbetweenfetalgrowthandchildhoodadhdsymptomscrosscohortreplication